Free Trial
OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

PURE Bioscience logo
$0.09 0.00 (-4.98%)
As of 02:30 PM Eastern

About PURE Bioscience Stock (OTCMKTS:PURE)

Advanced

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.07
$0.11
52-Week Range
$0.05
$0.21
Volume
14,437 shs
Average Volume
57,249 shs
Market Capitalization
$10.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PURE Stock News Headlines

Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
See More Headlines

PURE Stock Analysis - Frequently Asked Questions

PURE Bioscience's stock was trading at $0.0638 on January 1st, 2025. Since then, PURE stock has increased by 40.6% and is now trading at $0.0897.

PURE Bioscience (OTCMKTS:PURE) issued its quarterly earnings data on Monday, June, 16th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.49 million for the quarter.

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PURE Bioscience investors own include Meta Platforms (META), Hydrofarm Holdings Group (HYFM), Twilio (TWLO), NVIDIA (NVDA), Overstock.com (OSTK), Enphase Energy (ENPH) and Novavax (NVAX).

Company Calendar

Last Earnings
6/16/2025
Today
10/06/2025
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Chemicals
Current Symbol
OTCMKTS:PURE
CIK
1006028
Employees
10
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.35 million
Net Margins
-147.72%
Pretax Margin
-147.72%
Return on Equity
N/A
Return on Assets
-334.78%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.08
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$1.96 million
Price / Sales
5.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-2.99

Miscellaneous

Outstanding Shares
111,890,000
Free Float
63,171,000
Market Cap
$10.04 million
Optionable
Not Optionable
Beta
0.41

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:PURE) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners